FLJ35767 Blocking Peptide
- Known as:
- FLJ35767 Blocking Peptide
- Catalog number:
- 33r-7042
- Product Quantity:
- USD
- Category:
- -
- Supplier:
- Fitzgerald industries international
- Gene target:
- FLJ35767 Blocking Peptide
Related genes to: FLJ35767 Blocking Peptide
- Gene:
- TEX19 NIH gene
- Name:
- testis expressed 19
- Previous symbol:
- -
- Synonyms:
- FLJ35767
- Chromosome:
- 17q25.3
- Locus Type:
- gene with protein product
- Date approved:
- 2009-04-14
- Date modifiied:
- 2016-04-04
Related products to: FLJ35767 Blocking Peptide
Related articles to: FLJ35767 Blocking Peptide
- To identify molecular clusters and establish a scoring model based on mechanical stimulus-related genes (MSRGs) for predicting the prognosis of breast cancer patients and understanding the role of mechanical stimuli in the breast tumor microenvironment (TME). - Source: PubMed
Publication date: 2025/11/13
Yang ZeLou HaifengHuang YuqiaoGuo LingyunHuang YingfeiZhu GaoLi JingjiaLin YindanZhu JiangSun Yandi - In the Saudi population, colon cancer (CC) is connected with a high death rate due to frequent late-stage diagnosis. Consequently, early diagnosis of CC is crucial for improving treatment outcomes and reducing mortality. The purpose of the study was to evaluate the potential application of human testis expressed 19 (TEX19) as a cancer biomarker for better therapy and early CC identification. - Source: PubMed
Publication date: 2025/08/31
Almutairi Mikhlid HAlkhaldi Ahmad SAlrubie Turki MAlsoraie Waad AShaik Jilani PAlamri Abdullah MAlanazi MohammadAlkahtani Saad HAlmutairi Bader O - Non-obstructive azoospermia (NOA) belongs to male infertility due to spermatogenesis failure. However, evidence for cell type-specific abnormalities of spermatogenesis disorders in NOA remains lacking. We performed single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) on testicular tissues from patients with obstructive azoospermia (OA) and NOA. HE staining confirmed the structural abnormalities of the seminiferous tubules in NOA patients. We identified 12 germ cell subtypes (spermatogonial stem cell-0 [SSC0], SSC1, SSC2, diffing-spermatogonia [Diffing-SPG], diffed-spermatogonia [Diffed-SPG], pre-leptotene [Pre-Lep], leptotene-zygotene [L-Z], pachytene [Pa], diplotene [Di], spermatids-1 [SPT1], SPT2, and SPT3) and 8 Sertoli cell subtypes (SC1-SC8). Among them, three novel Sertoli cell subtype phenotypes were identified, namely SC4/immature, SC7/mature, and SC8/further mature Sertoli cells. For each germ or Sertoli cell subtype, we identified unique new markers, among which immunofluorescence confirmed co-localization of ST3GAL4, A2M, ASB9, and TEX19 and DDX4 (classical marker of germ cell). PRAP1, BST2, and CCDC62 were co-expressed with SOX9 (classical marker of Sertoli cell) in testes tissues also confirmed by immunofluorescence. The interaction between germ cell subtypes and Sertoli cell subtypes exhibits stage-specific-matching pattern, as evidenced by SC1/2/5/7 involving in SSC0-2 development, SC3 participating in the whole process of spermiogenesis, SC4/6 participating in Diffing and Diffed-SPG development, and SC8 involving in the final stage of SPT3. This pattern of specific interactions between subtypes of germ cell and Sertoli cell was confirmed by immunofluorescence of novel markers in testes tissues. The interaction was mainly regulated by the Notch1/2/3 signaling. Our study profiled the single-cell transcriptome of human spermatogenesis and provided many potential molecular markers for developing testicular puncture-specific marker kits for NOA patients. - Source: PubMed
Publication date: 2025/05/15
Wang ShiminWang HongxiangJin BichengYan HongliZheng QingliangZhao Dong - Globally, breast cancer in women is the fifth leading cause of cancer death. There is an urgent need to explore the molecular mechanism of breast cancer proliferation and metastasis. - Source: PubMed
Publication date: 2024/06/12
Liu HuantaoWang HeZhang HongyuYu MiaomiaoTang Yu - - Source: PubMed
Publication date: 2023/08/28
Xiao YuhanWang JieFeng DechaoZhang Chi